Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

The historical record shows that the battle to prevent and find cures for infectious disease will lead to a lower incidence of chronic, disabling diseases. At the same time, efforts to find ...

Historical redlining is linked to care utilization and fragmentation among patients with rheumatic conditions, highlighting the role of structural racism in these disparities.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...